Today, the VP, Corp. Contr of Innophos Holdings (NASDAQ: IPHS), Charles Brodheim, bought shares of IPHS for $74.26K.
Following this transaction Charles Brodheim’s holding in the company was increased by 6.44% to a total of $1.93 million.
See today’s analyst top recommended stocks >>
Based on Innophos Holdings’ latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $205 million and quarterly net profit of $10.89 million. In comparison, last year the company earned revenue of $179 million and had a net profit of $11.15 million. IPHS’s market cap is $957.7M and the company has a P/E ratio of 43.45. Currently, Innophos Holdings has an average volume of 48.64K.
Four different firms, including KeyBanc and Monness, currently also have a Buy rating on the stock.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Innophos Holdings, Inc. engages in the production of specialty ingredients solutions for the food, health, nutrition, and industrial markets. It operates through the following segments: Specialty Ingredients, Core Ingredients, and Co-Products and Other.
